Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).
- DOI
- 10.1093/milmed/usac362
- Published
- 2023 Jul 22
- Container
- Military medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/milmed/usac362,
title = {Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).},
author = {Paine R and Chasse R and Halstead ES and Nfonoyim J and Park DJ and Byun T and Patel B and Molina-Pallete G and Harris ES and Garner F and Simms L and Ahuja S and McManus JL and Roychowdhury DF},
year = {2023},
journal = {Military medicine},
doi = {10.1093/milmed/usac362},
url = {https://doi.org/10.1093/milmed/usac362}
}RIS
TY - JOUR TI - Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm). AU - Paine R AU - Chasse R AU - Halstead ES AU - Nfonoyim J AU - Park DJ AU - Byun T AU - Patel B AU - Molina-Pallete G AU - Harris ES AU - Garner F AU - Simms L AU - Ahuja S AU - McManus JL AU - Roychowdhury DF PY - 2023 JO - Military medicine DO - 10.1093/milmed/usac362 UR - https://doi.org/10.1093/milmed/usac362 ER -
APA
R, P., R, C., ES, H., J, N., DJ, P., T, B., B, P., G, M., ES, H., F, G., L, S., S, A., JL, M., & DF, R. (2023). Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).. Military medicine. https://doi.org/10.1093/milmed/usac362
Source records
- pubmed · retrieved 2026-09-25T23:30:25.232Z
- europe-pmc · retrieved 2026-09-25T23:30:25.249Z